Westwind Capital Takes Position in Tempus AI, Inc. (NASDAQ:TEM)

Westwind Capital purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 72,647 shares of the company's stock, valued at approximately $3,504,000. Tempus AI accounts for about 0.9% of Westwind Capital's holdings, making the stock its 21st biggest holding.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Nikko Asset Management Americas Inc. increased its stake in Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. grew its position in shares of Tempus AI by 240.5% during the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after purchasing an additional 1,950,862 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Tempus AI by 86,947.2% during the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after purchasing an additional 1,651,996 shares in the last quarter. Norges Bank purchased a new position in shares of Tempus AI during the fourth quarter valued at about $34,681,000. Finally, Mariner LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at about $31,187,000. 24.22% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Tempus AI news, CAO Ryan M. Bartolucci sold 6,073 shares of Tempus AI stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total value of $383,995.79. Following the transaction, the chief accounting officer now owns 47,799 shares in the company, valued at $3,022,330.77. This trade represents a 11.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Wayne A.I. Frederick sold 3,000 shares of Tempus AI stock in a transaction on Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the transaction, the director now owns 26,514 shares in the company, valued at approximately $1,207,447.56. This trade represents a 10.16% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 609,897 shares of company stock worth $41,397,783. 27.60% of the stock is owned by company insiders.

Tempus AI Stock Performance

Shares of TEM stock opened at $66.52 on Friday. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a 52 week low of $30.77 and a 52 week high of $91.45. The stock has a market capitalization of $11.52 billion and a PE ratio of -8.53. The firm has a 50 day moving average of $61.26 and a two-hundred day moving average of $53.30.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The business's quarterly revenue was up 75.4% compared to the same quarter last year. On average, research analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Bank of America raised their price objective on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research report on Wednesday. Piper Sandler raised their price objective on Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research report on Thursday, May 15th. BTIG Research initiated coverage on shares of Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 price target for the company. Needham & Company LLC reaffirmed a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Wednesday, May 7th. Finally, Morgan Stanley increased their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Tempus AI currently has a consensus rating of "Moderate Buy" and a consensus price target of $63.58.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.